全文获取类型
收费全文 | 2376篇 |
免费 | 112篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 95篇 |
妇产科学 | 21篇 |
基础医学 | 435篇 |
口腔科学 | 79篇 |
临床医学 | 287篇 |
内科学 | 540篇 |
皮肤病学 | 113篇 |
神经病学 | 46篇 |
特种医学 | 268篇 |
外科学 | 193篇 |
综合类 | 49篇 |
预防医学 | 83篇 |
眼科学 | 26篇 |
药学 | 165篇 |
中国医学 | 1篇 |
肿瘤学 | 114篇 |
出版年
2018年 | 24篇 |
2015年 | 30篇 |
2014年 | 24篇 |
2013年 | 88篇 |
2012年 | 36篇 |
2010年 | 44篇 |
2009年 | 41篇 |
2008年 | 32篇 |
2007年 | 51篇 |
2006年 | 56篇 |
2005年 | 38篇 |
2004年 | 28篇 |
2003年 | 34篇 |
2002年 | 28篇 |
2001年 | 38篇 |
2000年 | 34篇 |
1999年 | 40篇 |
1998年 | 85篇 |
1997年 | 96篇 |
1996年 | 107篇 |
1995年 | 73篇 |
1994年 | 75篇 |
1993年 | 76篇 |
1992年 | 43篇 |
1991年 | 39篇 |
1990年 | 45篇 |
1989年 | 69篇 |
1988年 | 59篇 |
1987年 | 48篇 |
1986年 | 54篇 |
1985年 | 39篇 |
1984年 | 56篇 |
1983年 | 29篇 |
1982年 | 31篇 |
1981年 | 39篇 |
1980年 | 49篇 |
1979年 | 23篇 |
1978年 | 27篇 |
1977年 | 36篇 |
1976年 | 40篇 |
1975年 | 37篇 |
1972年 | 24篇 |
1971年 | 22篇 |
1970年 | 28篇 |
1965年 | 50篇 |
1964年 | 50篇 |
1963年 | 47篇 |
1962年 | 41篇 |
1961年 | 41篇 |
1960年 | 65篇 |
排序方式: 共有2519条查询结果,搜索用时 15 毫秒
51.
The University of Oklahoma Medical Center has a comprehensive program of pediatric training, research and patient care. Establishment of the Oklahoma Health Center and its Children's Medical Center on the University campus will provide expanded opportunities for training and research in cooperation with other organizations concerned with child health and development. 相似文献
52.
Thrombocytopoietic properties of oncostatin M 总被引:1,自引:2,他引:1
Oncostatin M (OM) is a 28-kD glycoprotein that exhibits a panoply of biologic effects. Based on histologic observations of increased splenic megakaryocytes in nude mice implanted with an OM-secreting cell line, the thrombocytopoietic properties of OM in mice were investigated in culture and in vivo. Alone, OM did not induce megakaryocytic colony formation, but in combination with murine interleukin-3 (IL-3), OM markedly enhanced colony formation. The effects of OM on colony formation were similar to those of IL-6. OM alone augmented acetylcholinesterase in short-term marrow cultures. In normal mice, the administration of OM augmented platelet counts without increasing other circulating blood cell counts. The increment in counts exceeded that observed with IL-6. The kinetics of the OM response suggested that maximal increases in platelets occurred 3 days after the cessation of OM administration, irrespective of the duration of administration. In irradiated mice, OM administration accelerated platelet recovery and prevented the decrease in red blood cells observed in irradiated control animals. The data show that OM behaves as a megakaryocytic maturation factor in vitro and augments platelet production in vivo. Based on these animal data, OM may have potential clinical utility as a thrombocytopoietic agent. 相似文献
53.
54.
55.
56.
57.
58.
1. Three cases of hereditary hemolytic disease secondary to G-6-PD deficiency are described. Two of the cases were first cousins of Scotch-Irish-English descent and the mode of inheritance was believed to be sex-linked.The third case was of Turkish origin; no family studies were availale.2. The mothers, who were heterozygous for G-6-PD deficiency, showed onlyminimal expression of the defect, which was manifested by a slightly decreasedred cell survival in both mothers and an abnormal methemoglobin reductiontest in one of them.3. All three cases showed a more pronounced fall in erythrocyte ATP afterincubation with phenylhydrazine than that observed in primaquine-sensitiveNegroes whose red cells were less deficient in G-6-PD.4. It is suggested that the inability of the G-6-PD-deficient erythrocyte tomaintain adequate levels of ATP may be an important factor in the pathogenesis of the hemolytic process. Submitted on August 26, 1963 Accepted on October 24, 1963 相似文献
59.
Several Australian obesity management guidelines have been developed for general practice but, to date, implementation of these guidelines has been shown to be inadequate. In this review, we explore the barriers to obesity treatment and propose a four-stage plan to manage individuals with obesity in general practice using a framework of a multidisciplinary team.Funding: Novo Nordisk. 相似文献
60.